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Oketsu is a characteristic condition that plays an important role in Kampo, Japanese traditional medicine, and includes multiple
aspects of hemodynamic disorders. This study aims to clarify the microcirculation of Oketsu and the pharmacological effect of
Keishibukuryogan, an anti-Oketsu Kampo prescription, using live imaging techniques. Oral administration of Keishibukuryogan
induced significant vasodilation of murine subcutaneous arterioles compared to the preadministration level. This vasodilatation
peaked 60min after administration and persisted for 90min. The blood velocity in the subcutaneous capillary was also increased
by Keishibukuryogan in generally the same manner. In rat mesenteric arterioles, Keishibukuryogan administration improved
microhemodynamic parameters, including the resolution of erythrocyte congestion and the cell-free layer, which are representative
of Oketsu pathology. Live imaging revealed an increase of diaminofluorescein-2 diacetate fluorescence, a nitric oxide (NO) specific
reagent, in the arterial endothelium followingKeishibukuryogan administration.This fluorescence wasmost remarkable at vascular
bifurcations but was present throughout the mesenteric arterioles. This study demonstrates the successful imaging of Oketsu
pathology with respect to microcirculation and the anti-Oketsu effects of Keishibukuryogan, namely, vasodilation of arterioles,
increased blood velocity, and resolution of erythrocyte congestion. The anti-Oketsu effect of Keishibukuryogan is related to
endothelial NO production.
1. Introduction
Oketsu is a characteristic pathophysiology in Kampo, Japa-
nese traditional medicine, and oriental medicines, a con-
cept absent from western medicine. Oketsu is a condition
characterized by a disturbance in the flow of “Ketsu,” which
means blood and total body fluid. Although the direct trans-
lation of Oketsu to medical terminology is ischemia, Oketsu
represents a broader pathology status, which includes over-
sensitivity to cold, flushes, back pain, menstrual disorder,
hemorrhoids, and sleeping disorders. The circulation disor-
der aspect of Oketsu is not restricted to the arterial and
venous systems but extends to capillaries. Because this patho-
physiological concept is unique to oriental medicine, Kampo
prescriptions are widely used as therapeutic strategies for
Oketsu. However, much of the pathophysiology of Oketsu
and the pharmacological effects of anti-Oketsu drugs remain
unclear.
Blood circulation in the arterial and venous systems has
been analyzed in detail from the level of the aorta to small
vessels using a progression of techniques fromDoppler ultra-
sonography to magnetic resonance imaging. On the other
hand, technological difficulties are encountered in visualizing
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the hemodynamics of the capillary system, which is the key
site of Oketsu pathology. Moreover, it is known that nitric
oxide (NO) and reactive oxygen species (ROS) are closely
involved in microcirculation kinetics, and oxidative stress
plays a large role in the associated disorders [1]. However,
analysis of NO kinetics at a microcirculation level also entails
technical challenges.
In this study, we aimed to investigate the pharmacological
effect of Keishibukuryogan, a major anti-Oketsu prescrip-
tion, on microcirculation using cutting-edge live imaging
techniques. Specifically, live imaging of the effects of Keishi-
bukuryogan on subcutaneous vessels was performed using a
murine model. Further, we also evaluated NO production in
rat mesenteric arteries following Keishibukuryogan adminis-
tration using live imaging.
2. Materials and Methods
2.1. Materials. C57B/6 mice and Wistar rats were purchased
from Japan SLC (Hamamatsu, Japan). NG-Monomethyl-L-
arginine acetate (L-NMMA), diaminofluorescein-2 diacetate
(DAF-2 DA), and urethane were obtained from Dojindo
Molecular Technologies, Inc. (Kumamoto, Japan), Goryo
Chemical (Sapporo, Japan), and Sigma-Aldrich Japan (Tokyo,
Japan), respectively. Confocal laser scanning microscope
images were obtained using an LSM 700 manufactured by
Zeiss (Oberkochen, Germany) and analyzed with ImageJ
ver.1.45s image analysis software (NIH, USA). Keishibuk-
uryogan dry extract granules were provided by Tsumura Co.,
Ltd. (Tokyo, Japan). The Keishibukuryogan extract used in
this study contained Cinnamomi Cortex, Paeoniae Radix,
Semen Persicae, Poria Sclerotium, and Moutan Cortex. The
daily dose of Keishibukuryogan extract (7.5 g per day) con-
tained 3 g of each of the above ingredients. Live imaging
experiments were carried out at the Timelapse Vision Inc.
under the approval of the local ethics committee.
2.2. Live Imaging of Murine Subcutaneous Vessels. Male
C57B/6 mice (8 weeks old) were used in experiments (𝑛 = 3).
The experiments were conducted under urethane (1.5 g/kg,
i.s.) anesthesia. Following an incision, the ventral side skin of
the mouse was peeled off, and the subcutaneous blood vessel
was positioned on a glass plate.The vessel was covered with a
thin vinylidene chloride film and fixed to prevent moisture
evaporation. Keishibukuryogan was suspended in hot dis-
tilled water at 100mg/mL and cooled to room temperature.
A dose of 300mg/kg was transesophageally administered to
the mice using a gastric tube.
For live imaging, microcirculation of the subcutaneous
blood vessels was recorded using real-time imaging from
before Keishibukuryogan administration and every following
30min up to a total of 180min. The inner vessel diameter
and blood velocities were analyzed from the obtained images
with ImageJ ver.1.45s software. The changes in diameter and
velocities were evaluated in both arterioles (10 to 20𝜇m) and
capillaries (<10 𝜇m).The inner diameter of vessels and blood
vessel velocities were analyzed at 0, 30, 60, 90, 120, 150, and
180min.The diameter of blood vessels was measured in trip-
licate at three points, for a total of ninemeasurements for each
animal, on the screens.The blood flow velocity was calculated
based on measurements of erythrocyte locations within the
capillaries in individual images. The distance travelled by
individual erythrocytes was divided by the elapsed time to
provide the blood flow velocity (𝜇m/sec). Blood flow velocity
was determined by performing quadruplicate measurements
at a single point and reported as average values. In addition,
we measured the heart rate of animals for evaluation of
hemodynamics.
2.3. Live Imaging of Microcirculation and Nitric Oxide Release
in Rat Mesenteric Arteries. Female Wistar rats (9 weeks old)
were used (𝑛 = 3 for each group), and experiments were
conducted under urethane (1.5 g/kg) anesthesia following
overnight fasting. After an approx. 2 cm incision was made in
the peritoneum, the ileum was drawn out and the mesentery
was spread on a glass plate, which was covered by a thin
vinylidene chloride film to prevent moisture evaporation.
The imaging site was determined using an intravital micro-
scope, and a catheter was inserted into a vessel upstream
of the set site to obtain a perfusion route. Live imaging
was performed in the same manner as for the murine
subcutaneous blood vessels. As shown in Figure 4(a), sites
reflecting upstream, middle, and peripheral sections of the
mesenteric artery were established in each rat. The effects
of Keishibukuryogan administration were investigated using
the following three groups: the control group given DAF-
2DA only, the Keishibukuryogan group given DAF-2DA and
Keishibukuryogan, and the L-NMMAgroup givenDAF-2DA
and L-NMMA. For the Keishibukuryogan group, 300mg/kg
of a 100mg/mL solution of Keishibukuryogan was adminis-
tered to the rats using transesophageal gastrotubing.
NO production was investigated using the NO-specific
fluorescent indicator DAF-2 (the optimum excitation wave-
length is 495 nm and fluorescence wavelength is 515 nm).
After live imaging of microcirculation, DAF-2DA (50 𝜇M)
was administered through the route and perfused locally for
3min. Immediately thereafter, a baseline fluorescence image
was obtained using confocal laser scanning microscopy
which was set with the excitation wavelength at 488 nm
by using argon laser and the fluorescence was detected
through a 492 nm long pass filter. In the Keishibukuryogan
group, after confirming the disappearance of fluorescence,
Keishibukuryogan was administered intragastrically 30min
later. Then, after another 30min, DAF-2 DA was perfused
again and a second round of images were obtained at the
same site as the initial imaging, and the change in fluores-
cence intensity of DAF-2 before and after administration of
Keishibukuryogan was analyzed. In each group, images were
acquired in a total of 6 to 9 regions from 3 rats. In the control
group, the second fluorescence images were obtained 60min
after the initial baseline imaging, without any treatment
between the first and second perfusion of DAF-2DA. The
other process was performed in the same manner as for the
Keishibukuryogan group. In the L-NMMA group, 25mg/kg
of the NO synthase inhibitor L-NMMA was intravascularly
administered 5min before the second DAF-2DA perfusion,
and a second dose of L-NMMA was added to the DAF-2DA
solution at a final concentration of 2.5mg/mL. Imaging was
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performed in the same manner as for the control group. For
the analysis, regions of interest were established at the site
of observation, and the average fluorescence intensity in that
area was obtained using ImageJ software.
2.4. Statistical Analysis. Statistical analysis was performed
using Prism 6 for Mac OS X (Graphpad Software Inc., La
Jolla, CA, USA) with a multiple comparison test using the
Holm-Sidak method using one-way ANOVA with repeated
measurement.
3. Results
3.1. Keishibukuryogan Induced Vasodilation and Improved
Blood Flow Velocity in Murine Subcutaneous Vessels. Rep-
resentative images of live imaging of subcutaneous blood
vessels in mice are shown in Figures 1(a)–1(e), and changes
in vessel diameter at chosen sites are shown in Figure 1(f).
Total changes in vessel diameter of 3 different mice following
Keishibukuryogan administration are shown in Figure 2(a),
and changes in blood flow velocity are shown in Figure 2(b).
Significant dilation of the vessels peaked after 60min and
effects lasted for a total of 90min on the arterioles (𝑝 < 0.05).
No significant changes were observed in the capillaries.
Blood flow velocities were evaluated in the vessels with
the diameter of arterioles (10 to 20𝜇m) and capillaries
(<10 𝜇m). The velocities varied considerably depending on
the site and were 701 ± 257 and 298 ± 149 𝜇m/sec, respec-
tively (mean ± SE), immediately prior to Keishibukuryogan
administration. A significant increase in blood flow velocity
was observed at 60min after administration in the capillaries
(𝑝 < 0.05), but this decreased after 90min. Before the
administration of Keishibukuryogan, the heart rate of the
mice was 651 ± 11 bpm.The heart rates at 30, 60, 90, 120, 150,
and 180min after the administration were 683 ± 8, 673 ± 4,
679 ± 9, 670 ± 12, 674 ± 6, and 676 ± 5% (mean ± SE), and no
significant differences were observed.
3.2. Keishibukuryogan Improved Oketsu Accompanied by
Nitric Oxide (NO) Increase in Rat Mesenteric Arteries. Rep-
resentative images of live imaging of the rat mesenteric arte-
rioles are shown in Figure 3. Meanwhile, typical fluorescence
images of rat mesenteric arterioles are shown in Figure 4, and
changes in fluorescence intensity are shown in Figure 5.
In rat mesenteric arterioles before Keishibukuryogan
administration, erythrocyte congestion in the capillaries and
broadening of the cell-free layer, in which the plasma layer
lacks erythrocytes, the so-called plasma pocket phenomenon,
were observed (Figure 3). These circulatory deficiencies cor-
responded to aspects of Oketsu. Further, about 60min after
Keishibukuryogan administration, the circulatory deficien-
cies disappeared, and consistent blood flow, as observed in
other regions, was confirmed.
In fluorescence imaging, fluorescence was observed in
arteriolar vascular endothelial cells in the control group
even in an unstimulated state, reflecting constitutive NO
production in the endothelium (Figure 4(b)). The increase
of fluorescence in the endothelium with the second DAF-
2DA administration was 101.0 ± 2.4% as compared to the
first imaging in the control group, which did not indicate
a significant change (Figure 5). On the other hand, in the
Keishibukuryogan group, a significant increase in DAF-2 flu-
orescence was observed after administration (157.7 ± 10.9%,
𝑝 < 0.01). This increase in fluorescence was widely observed
from upstream to the periphery of the mesenteric artery,
while remarkable changes were observed at bifurcations, as
shown in Figure 4(b). On the other hand, in the L-NMMA
group, DAF-2 fluorescence intensity significantly decreased
(74.2 ± 3.6%, 𝑝 < 0.05) as compared with the control group.
4. Discussion
Oketsu is a condition that is particularly emphasized in
Kampo and oriental medicine and is considered to con-
sist of erythrocyte factors including membrane charge and
deformability, blood viscosity, thrombocytic agglutinability,
and endothelial function [2]. In this study, we aimed to clarify
the blood circulation and NO dynamics in Oketsu pathology
using live imaging techniques.
A murine model was employed for the subcutaneous
blood vessel experiment and a rat model was used for
investigation of NO dynamics in our study. Because murine
subcutaneous vessels are composed of a series of vascu-
latures from large arteries to capillaries, they are suitable
for measuring the change in blood vessel diameter due to
contraction and relaxation. On the other hand, the diameters
of rat mesenteric vessels are varied, and the reactivity is
relatively poor. Moreover, our method of detecting NO by
intravascular perfusion ofDAF-2DA required cannulation on
a vessel upstream of the observation area, and this process
raised a technical limitation depending on the size of animals.
There are currently no established animal models of
Oketsu pathophysiology. In this study, we examined con-
ditions that are similar to Oketsu, by placing the exposed
abdominal lateral skin on a fixing glass plate for the murine
subcutaneous vessel model and by extracting the ileum
from the abdomen and placing it on a fixing glass plate
for the rat mesenteric arteriole investigation. As a result,
erythrocyte congestion in the arterioles and capillaries and
expansion of the cell-free layer were observed. While we
cannot assume that these conditions mimic the pathology
of Oketsu exactly, at a minimum, both erythrocyte and
vascular factors, that is, erythrocyte congestion and vascular
contraction, were reproduced. As a model of peripheral
congestion in human small arteries, but not Oketsu, Ong
and colleagues reported a series of studies using arterioles
within the rat cremaster muscle, which resembles the rat
mesentery in this study [3]. Particularly, generation of the
plasma pocket phenomenon, involving the expansion of
the cell-free layer, was demonstrated in this study and in
microcirculation studies in general;moreover, the association
with NO and ROS kinetics has been previously reported [4–
6]. Because the situation of Oketsu reflects both erythrocyte
and vascular factors, the existence of this cell-free plasma
layer may be closely related to Oketsu pathology. Our
results showed the anti-Oketsu effects of Keishibukuryogan,
via its effect on vasodilation, improvement of blood flow
velocity, and reduction of erythrocyte congestion and the
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Figure 1: Live imaging of murine subcutaneous vessels before and after the administration of Keishibukuryogan. Representative images
are shown. (a) shows the image before Keishibukuryogan administration, while (b)–(e) show images of the same site at 30, 60, 90, and
120min after administration. (f) shows the change in vascular diameter at sites D1–D3 shown in (a)–(e). Maximum vasodilation from 60
to 90min after Keishibukuryogan administration was confirmed. The vascular diameter was restored to preadministration levels at approx.
180min.
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Figure 2: Changes in vasodiameter (a) and blood flow velocity (b) of murine subcutaneous arterioles (◼) and capillaries (e) before and after
administration of Keishibukuryogan. Both (a) and (b) are expressed as a percentage, with preadministration expressed as 100%. ∗𝑝 < 0.05.
(a) (b)
Figure 3: Live imaging of rat mesenteric arterioles before (a) and 60min after (b) the administration of Keishibukuryogan. Representative
images are shown. Prior to Keishibukuryogan administration, erythrocyte congestion and cell-free plasma layer (plasma pocket) as indicators
of Oketsu status (shown by arrows) were observed. At 60min after administration, these Oketsu symptoms were resolved.
cell-free layer, which are in agreement with the concept of
Oketsu.
In this study, as the arterioles expanded, blood flow
velocity at the same site decreased whereas in the capillary
vessels blood flow velocity simultaneously increased (Figures
2(a) and 2(b)). Since the change of capillary diameter is much
smaller than that in the arteriole, the increase in capillary
blood flow indicates that the blood volume at the observation
site increased. Even in the arteriole, the actualmeasured value
of the blood flow velocity at 60min after the administration
is 66% of the velocity before the administration and it is
higher than the predicted value (51%) calculated from the
blood vessel diameter on the assumption that the blood
flow rate does not change. Thus, the blood flow volume in
the arteriole also increased. Consequently, Keishibukuryogan
increased the blood flow volume with the increase in blood
vessel diameter and blood flow velocity as its anti-Oketsu
effect.
NO is considered to be an endothelium-derived relaxing
factor and is thus regarded as a physiologically active sub-
stance of extreme importance in circulatory regulation [1].
AlthoughNO is expected to be intimately involved inOketsu,
few studies have investigated this relationship, especially in
vivo [7–9]. We previously reported that Kangenkaryu, an
anti-Oketsu reagent, increased NO metabolites and affected
the NO-superoxide balance in humans [10]. A series of
studies from Ng and colleagues revealed the close rela-
tion between the formation of asymmetric cell-free layer
widths and its influence on the uneven distribution of NO-
superoxide balance in the downstream flow of an arteriolar
bifurcation [5, 6]. These reports suggested the close relation-
ship betweenOketsu andNOandROSdynamics.Meanwhile,
Keishibukuryogan is a representative anti-Oketsu drug in
Kampo. The in vitro relationship between its main phar-
macological anti-Oketsu effect and NO has been reported,
in which Keishibukuryogan showed inhibitory effects on
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Figure 4: Imaging of the mesenteric arterioles before and 60min
after the administration of Keishibukuryogan in rats. Representative
images are shown. (a) indicates the site of the mesentery used for
imaging and (b) shows the DAF-2 fluorescence images of the
corresponding sites. The images of (a) (1)–(3) and (b) (1)–(3)
correspond to the same site. Increases in NO levels were observed
in all sites following Keishibukuryogan administration, particularly
in endothelial cells.
inflammatory cytokines in skin endothelial cells [11]. In
regard to the relationship with oxidative stress, the suppres-
sion of lipid peroxidation on erythrocytemembranes induced
by 2,2-azo-bis(2-amidinopropane) dihydrochloride (AAPH)
and the suppression of neuronal cell death induced by sodium
nitroprusside have been investigated [12, 13]. Moreover,
regarding the components of Keishibukuryogan, cinnamic
aldehyde contained in cinnamon, paeoniflorin contained in
Paeonia lactiflora, and amygdalin contained in Semen Per-
sicae are known to increase peripheral blood flow [14–16],
and cinnamic aldehyde and paeoniflorin reportedly showed
anti-inflammatory effects involvingNO-related pathways [15,
17–20]. These results strongly suggest that the anti-Oketsu
∗
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0
50
100
150
200
(%
)
Figure 5: Changes in NO levels following the administration of
Keishibukuryogan. DAF-2 fluorescence intensity was significantly
increased in the Keishibukuryogan group compared with the con-
trol group. Also, DAF-2 fluorescence intensity was significantly
decreased in the L-NMMA group. ∗𝑝 < 0.05, ∗∗𝑝 < 0.01.
effect of Keishibukuryogan is closely related to NO and ROS;
however, most of these reports involved in vitro studies, with
few reports of in vivo effects [21].
Our imaging study of rat mesenteric arterioles clearly
imaged the improvement of Oketsu status following Keishi-
bukuryogan administration, evidenced by the increase in
DAF-2 fluorescence. Since DAF-2 has high NO speci-
ficity [22] and L-NMMA treatment decreased the fluores-
cence intensity, this indicates that the anti-Oketsu effect
of Keishibukuryogan can be attributed to a NO-related
mechanism. An increase in NO production was observed
mainly in the endothelium 30min after Keishibukuryogan
administration, suggesting that eNOS was the target enzyme
of Keishibukuryogan. This finding is in agreement with a
previous in vivo study showing effects of Keishibukuryogan
on both eNOS and iNOS in the aorta of an adjuvant-induced
arthritis model [21]. On the other hand, the vasodilation
effect of Keishibukuryogan persisted for a total of 120min
after administration, whereas the increased blood flow was
maintained for only up to 60min, subsequently decreasing
despite the increases in vessel diameter. This suggests that
Keishibukuryogan has rapid pharmacological effects in ery-
throcytes themselves; however, further studies are warranted
to clarify this point.
This study is the first live imaging of Oketsu pathology
and the anti-Oketsu pharmacological effects of Keishibuk-
uryogan. Additionally, we revealed the relationship between
NO andOketsu andKeishibukuryogan effects using live fluo-
rescence imaging. BecauseOketsu is a traditional and compli-
cated concept, its translation to modern scientific termi-
nology has been challenging. While there continue to be a
number of technical limitations, our approach represents a
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promising method to clarify the concept of Kampo patho-
physiology as well as the pharmacology of Kampo prescrip-
tions.
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